EXOSOME DIAGNOSTICS

exosome-diagnostics-logo

Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technology makes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.

#SimilarOrganizations #People #Financial #Website #More

EXOSOME DIAGNOSTICS

Social Links:

Industry:
Biotechnology Genetics Health Care Health Diagnostics

Founded:
2008-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.exosomedx.com

Total Employee:
101+

Status:
Active

Contact:
1(617) 588-0500

Email Addresses:
info@exosomedx.com

Total Funding:
112.08 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics


Similar Organizations

altheadx-logo

AltheaDx

AltheaDx offers molecular diagnostics and PCR-based services such as molecular biomarker discovery, assay development and assay validation.

cofactor-genomics-logo

Cofactor Genomics

Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.

human-longevity-logo

Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

caredx-logo

CareDx

CareDx is a novel mol­e­c­u­lar diagnos­tics com­pany.


Current Advisors List

marco-boorsma_image

Marco Boorsma Board Observer @ Exosome Diagnostics
Board_observer

kapil-dhingra_image

Kapil Dhingra Member of the Board of Directors @ Exosome Diagnostics
Board_member

joseph-boystak_image

Joseph Boystak Board of Director @ Exosome Diagnostics
Board_member

geert-jan-mulder_image

Geert Jan Mulder Board of Director @ Exosome Diagnostics
Board_member

steven-l-soignet_image

Steven L. Soignet Board of Director @ Exosome Diagnostics
Board_member

Current Employees Featured

william-j-kelly_image

William J. Kelly
William J. Kelly Chief Financial Officer @ Exosome Diagnostics
Chief Financial Officer
2014-05-01

shelly-hirshon_image

Shelly Hirshon
Shelly Hirshon Co-Founder @ Exosome Diagnostics
Co-Founder
2008-05-01

raaj-venkatesan_image

Raaj Venkatesan
Raaj Venkatesan VP of Affairs & Quality @ Exosome Diagnostics
VP of Affairs & Quality
2015-12-01

mikkel-noerholm_image

Mikkel Noerholm
Mikkel Noerholm Director of Product Development @ Exosome Diagnostics
Director of Product Development
2014-07-01

johan-skog_image

Johan Skog
Johan Skog Chief Scientific Officer and Vice President @ Exosome Diagnostics
Chief Scientific Officer and Vice President
2018-08-01

Founder


james-r-mccullough_image

James R. McCullough

johan-skog_image

Johan Skog

shelly-hirshon_image

Shelly Hirshon

Investors List

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series C - Exosome Diagnostics

btovpartners_image

btov Partners

btov Partners investment in Series C - Exosome Diagnostics

cd-venture_image

CD-Venture

CD-Venture investment in Series C - Exosome Diagnostics

blue-ridge-capital_image

Blue Ridge Capital

Blue Ridge Capital investment in Series C - Exosome Diagnostics

ngn-capital_image

NGN Capital

NGN Capital investment in Series C - Exosome Diagnostics

tiger-infrastructure-partners-2_image

Tiger Infrastructure Partners

Tiger Infrastructure Partners investment in Series C - Exosome Diagnostics

venture-capital_image

Arcus Ventures

Arcus Ventures investment in Series C - Exosome Diagnostics

tiger-management-corporation_image

Tiger Management Corporation

Tiger Management Corporation investment in Series B - Exosome Diagnostics

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series B - Exosome Diagnostics

venture-capital_image

Arcus Ventures

Arcus Ventures investment in Series B - Exosome Diagnostics

Official Site Inspections

http://www.exosomedx.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.23 K

  • Host name: a184-27-6-158.deploy.static.akamaitechnologies.com
  • IP address: 184.27.6.158
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Exosome Diagnostics"

ExosomeDx and ZERO - The End of Prostate Cancer

Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of Prostate Cancer, the leading national nonprofit organization in the fight against prostate cancer. ZERO advances research, …See details»

Exosome Diagnostics - Crunchbase Company Profile

Organization. Exosome Diagnostics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»

Investors | Bio-Techne Exosome

ExosomeDx is now part of Bio-Techne. Please see our Bio-Techne investors site. Bio-Techne Investors (844) 396-7663 exosomedx.info@bio-techne.com 266 Second Ave, Suite 200 …See details»

Exosome Diagnostics, a Bio-Techne brand | LinkedIn

Exosome Diagnostics, a Bio-Techne brand Biotechnology Research Waltham, MA 8,154 followers ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and guide ...See details»

Exosome Diagnostics - Forbion

Www.exosomedx.com 840 Memorial Drive, Suite 3 Cambridge MA 02139 United States Worked on by. Geert-Jan Mulder, MD Managing Partner. Geert-Jan Mulder MD is a co-founding partner of Forbion who has led several deals in …See details»

ExosomeDx

Every 5 minutes in the U.S., two men are diagnosed with prostate cancer and 1 in 8 men will be diagnosed with prostate cancer in their lifetime, according to the American Cancer Society.See details»

Getting Started with the ExoDx Prostate Test - YouTube

Mar 31, 2021 Leveraging the power of exosomes to determine risk for clinically significant prostate cancer with an At-Home Collection Kit.Learn More: https://www.exosomed...See details»

ExoDx Physician Information - Prostate Cancer Markers

The ExoDx Prostate Test, EPI, is a urine-based, liquid biopsy test indicated for men 50 and older with a PSA of 2-10 ng/mL. This PSA range is ambivalent and considered a “grey zone”, with valid concern for referring men for biopsies …See details»

Press Releases: ExosomeDx

Feb 11, 2021 Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of …See details»

Clinical Utilization of Exosomes as Biomarkers

By ExosomeDx, a Bio-Techne Brand. Life Science Posters Exosomes are secreted by all living cells into all biofluids and provides a snapshot of a living process; Testing with a stable sample, amenable to frozen storage from CSF, …See details»

Taking Charge of Your Prostate Health - ExosomeDx

Online at exosomedx.com for more information. 16 Exosome Diagnostics was founded in 2008 by Johan Skog, PhD after a discovery that exosomes carry RNA biomarkers that can be used …See details»

ExosomeDx

Thank you for your interest in the ExoDx Prostate Test . The ExoDx Prostate test is a simple, non-invasive urine test to help determine the prostate biopsy decision.See details»

Integrating ExosomeDx with Prostate Cancer Diagnostics for …

Jan 23, 2025 ExosomeDx scores provide clinicians with a quantifiable tool for estimating the likelihood of detecting high-grade prostate cancer, defined as Gleason 7 or higher. The score …See details»

Exosome Diagnostics Company Profile | Management and

Exosome Diagnostics Profile and History. Exosome Diagnostics is a privately held company focused on developing and commercializing revolutionary biofluid-based diagnostics to deliver …See details»

Liquid Biopsy Test for Prostate Cancer - ExosomeDx

What is the ExoDx™ Prostate Test? The ExoDx™ Prostate Test is a simple, non-DRE, urine-based, liquid biopsy test indicated for men 50 years of age and older with a prostate-specific …See details»

Entering the Chat Room of Cancer cells: How They Talk And

These small exosome packages act as communication vehicles between cells, much like todays Twitter messages and by intercepting this communication we can now listen in on the cells …See details»

What does the ExoDx prostate cancer test measure? - PC Markers

The ExosomeDx test, commonly called the ExoDx test, is used in addition to the PSA test and other standard of care data points (including age, race, and family history) to help healthcare …See details»

Exosomes in Skin Care | The Strategist - New York Magazine

Apr 30, 2025 By Tembe Denton-Hurst, a writer at the Strategist covering beauty and books. She joined the site in 2020. Previously, she wrote about beauty and culture for Nylon and Elle.See details»

For Patients: How to Order the ExoDx Prostate Test - ExosomeDx

Tips: Ensure Your ExoDx Prostate Test is Successful. A few tips to ensure that your sample does not get rejected and need to be resubmitted. Ensure the sample collection container and …See details»

The ExoDx Prostate Test (EPI) - ExosomeDx

Variations across guidelines, no organization recommends routine PSA testing, and all endorse some form of shared decision-making before testing. If screening is performed, it should …See details»

linkstock.net © 2022. All rights reserved